New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...
1don MSN
An off-the-shelf immunotherapy for targeting solid tumors: Ready-to-use CAR-NKT cells show promise
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...
"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...
The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...
Chimeric antigen receptor (CAR) T-cell therapy has shown efficacy in blood cancers — with six CAR T-cell products now approved by the US Food and Drug Administration (FDA) to treat six hematologic ...
Add Yahoo as a preferred source to see more of our stories on Google. In a trailblazing advancement in cancer therapy, researchers at Korea Advanced Institute of Science and Technology (KAIST) have ...
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...
The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...
Morning Overview on MSN
The world’s rarest cancer: The shocking story of the only known case
The rarest cancer on record did not begin in a human organ at all. It started inside a parasite, then crossed a biological ...
Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer. Discovery of a subset of high-risk progenitor cells that reside in fallopian tube ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results